
Metbetic GL 2mg/500mg Tablet SR
Marketer
Cadila Pharmaceuticals Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg)
Overview Metbetic GL 2mg/500mg Tablet SR
Diabetol Duo 2mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Diabetol Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, increasing the risk of complications such as nephropathy, retinopathy, neuropathy, and peripheral vascular disease. This medication complements a comprehensive diabetes management plan incorporating a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms like sweating, vertigo, cephalalgia, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential to mitigate this risk. Alcohol consumption should be limited due to its hypoglycemic potential. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is possible. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are recommended.
Primary Ingredients of Metbetic GL 2mg/500mg Tablet SR
No text provided. Please provide the text you want me to rephrase.
Uses of Metbetic GL 2mg/500mg Tablet SR
Managing Type 2 diabetes
Major Benefits of Metbetic GL 2mg/500mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Metbetic GL 2mg/500mg Extended-Release Tablets should be taken with a meal.
Common Side effects of Metbetic GL 2mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Metbetic GL 2mg/500mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire tablet without chewing, crushing, or breaking it. The Metbetic GL 2mg/500mg Sustained-Release tablet should be taken with a meal.
How Metbetic GL 2mg/500mg Tablet SR works:
Metformin/Glimepiride 500mg/2mg extended-release tablets (Metbetic GL) combine two distinct antidiabetic agents to manage blood sugar. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts through a triple mechanism: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol consumption with Metbetic GL 2mg/500mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Use of Metbetic GL 2mg/500mg SR tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Consult your doctor for advice.
Breast feedingUNSAFE
Extended-release Metbetic GL tablets (2mg/500mg) are contraindicated for breastfeeding mothers due to potential infant toxicity.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Metbetic GL 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Metbetic GL 2mg/500mg SR tablets. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.
LiverCAUTION
Individuals with liver impairment should use Metbetic GL 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, Metbetic GL 2mg/500mg SR tablets are typically initiated at a low dose; however, their use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Metbetic GL 2mg/500mg Tablet SR :
Should you forget a Metbetic GL 2mg/500mg Tablet SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metbetic GL 2mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes medication |
